Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-315
Status:
Terminated
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
Primary: To assess the safety and tolerability of ascending multiple oral doses of SAM-315,
an investigational drug, in healthy young adult and elderly subjects.
Secondary: To assess the Pharmacokinetic and Pharmacodynamic profiles of multiple oral doses
of SAM-315 in healthy young adult and elderly subjects.